Effects of Berberine on Cell Cycle, DNA, Reactive Oxygen Species, and Apoptosis in L929 Murine Fibroblast Cells. 2015

Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
College of Animal Science and Technology, Anhui Agricultural University, 130 Changjiang West Road, Hefei, Anhui 230036, China.

Berberine, an isoquinoline alkaloid isolated from several traditional Chinese herbal medicines (TCM), exhibits a strong antimicrobial activity in the treatment of diarrhea. However, it causes human as well as animal toxicity from heavy dosage. The present study was conducted to investigate the cytotoxicity of berberine and its possible trigger mechanisms resulting in cell cycle arrest, DNA damage, ROS (reactive oxygen species) level, mitochondrial membrane potential change, and cell apoptosis in L929 murine fibroblast (L929) cells. The cells were cultured in vitro and treated with different concentrations of berberine for 24 h. The results showed that cell viability was significantly decreased in a subjected dose-dependent state; berberine concentrations were higher than 0.05 mg/mL. Berberine at a concentration above 0.1 mg/mL altered the morphology of L929 cells. Cells at G2/M phase were clear that the level of ROS and cell apoptosis rates increased in 0.1 mg/mL group. Each DNA damage indicator score (DIS) increased in groups where concentration of berberine was above 0.025 mg/mL. The mitochondrial membrane potential counteractive balance mechanics were significantly altered when concentrations of berberine were above 0.005 mg/mL. In all, the present study suggested that berberine at high dosage exhibited cytotoxicity on L929 which was related to resultant: cell cycle arrest; DNA damage; accumulation of intracellular ROS; reduction of mitochondrial membrane potential; and cell apoptosis.

UI MeSH Term Description Entries

Related Publications

Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
June 2009, International journal of oncology,
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
August 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
February 2022, Toxicology in vitro : an international journal published in association with BIBRA,
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
January 2019, Anti-cancer agents in medicinal chemistry,
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
October 2021, Molecules (Basel, Switzerland),
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
February 2013, Experimental and molecular pathology,
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
June 2012, Leukemia research,
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
May 2008, Toxicology and applied pharmacology,
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
September 2008, Journal of pharmacological sciences,
Manman Gu, and Jing Xu, and Chunyang Han, and Youxi Kang, and Tengfei Liu, and Yanfei He, and Yanfei Huang, and Cuiyan Liu
October 2017, Interdisciplinary toxicology,
Copied contents to your clipboard!